# Consano Bio, Inc. funding rounds and investors

As of 14 Oct 2026, Consano Bio, Inc. has raised $15M across 1 verified round on record; latest: $15M Series A led by Conviction Partners, announced 10 Sep 2026.

A clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions

Website: https://www.consanobio.com  
Headquarters: Greater Boston area  
Page: https://fireround.dev/companies/consano-bio

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-09-10 | Series A | $15M | Conviction Partners | none named | [consanobio.com](https://consanobio.com/2026/10/05/consano-bio-raises-more-than-15-million-in-oversubscribed-financing-to-advance-c-1101-in-chronic-painful-lumbosacral-radiculopathy-chronic-sciatica), [prnewswire.com](https://www.prnewswire.com/news-releases/consano-bio-announces-peer-reviewed-publication-supporting-the-therapeutic-potential-of-c-1101-in-chronic-painful-lumbosacral-radiculopathy-lsr-or-chronic-sciatica-302874437.html), [prnewswire.com](https://www.prnewswire.com/news-releases/consano-bio-raises-more-than-15-million-in-oversubscribed-financing-to-advance-c-1101-in-chronic-painful-lumbosacral-radiculopathy-chronic-sciatica-302897596.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.